BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2529779)

  • 1. Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs.
    Lee RW; Gay RG; Goldman S
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1062-7. PubMed ID: 2529779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism for decrease in cardiac output with atrial natriuretic peptide in dogs.
    Lee RW; Goldman S
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H760-5. PubMed ID: 2522284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of natriuretic peptides and nitroprusside on venous function in trout.
    Olson KR; Conklin DJ; Farrell AP; Keen JE; Takei Y; Weaver L; Smith MP; Zhang Y
    Am J Physiol; 1997 Aug; 273(2 Pt 2):R527-39. PubMed ID: 9277535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and peripheral circulatory responses to angiotension and vasopressin in dogs.
    Lee RW; Standaert S; Lancaster LD; Buckley D; Goldman S
    J Clin Invest; 1988 Aug; 82(2):413-9. PubMed ID: 3403712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does atrial natriuretic factor protect against right ventricular overload? I. Hemodynamic study.
    Ou LC; Sardella GL; Hill NS; Thron CD
    J Appl Physiol (1985); 1989 Oct; 67(4):1606-11. PubMed ID: 2529240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term increases in plasma ANP on angiotensin II-induced hypertension.
    Granger JP; Blaine EH; Stacy DL; La Rock MJ
    Am J Physiol; 1990 May; 258(5 Pt 2):H1427-31. PubMed ID: 2140020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin and atrial natriuretic peptide on the cerebral circulation.
    Tamaki K; Saku Y; Ogata J
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):318-25. PubMed ID: 1532178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral circulatory control of preload-afterload mismatch with angiotensin in dogs.
    Lee RW; Lancaster LD; Buckley D; Goldman S
    Am J Physiol; 1987 Jul; 253(1 Pt 2):H126-32. PubMed ID: 3605358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of decreased cardiac output during ANP infusion in conscious anephric dogs.
    Mizelle HL; Gaillard CA; Manning RD; Hall JE
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R120-5. PubMed ID: 1531105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II modulates the intrarenal effects of atrial natriuretic peptide.
    Siragy HM; Lamb NE; Rose CE; Peach MJ; Carey RM
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F545-51. PubMed ID: 2970801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide decreases cardiac output independent of coronary vasoconstriction.
    Burnett JC; Rubanyi GM; Edwards BS; Schwab TR; Zimmerman RS; Vanhoutte PM
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):313-8. PubMed ID: 2962199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
    Höhne C; Drzimalla M; Krebs MO; Boemke W; Kaczmarczyk G
    J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
    Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
    Doorenbos CJ; Blauw GJ; van Brummelen P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and neurohumoral cardiovascular effects of atrial natriuretic peptide.
    Woods RL; Oliver JR; Korner PI
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):177-85. PubMed ID: 2468943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
    Edwards BS; Schwab TR; Zimmerman RS; Heublein DM; Jiang NS; Burnett JC
    Circ Res; 1986 Dec; 59(6):663-7. PubMed ID: 2949886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atrial natriuretic peptide on angiotensin II-induced antinatriuresis in anesthetized dogs.
    Tomura Y; Hisa H; Satoh S
    Biol Pharm Bull; 1995 Sep; 18(9):1211-4. PubMed ID: 8845807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential haemodynamic effects of atrial natriuretic peptide (ANP) in normotensive and spontaneously hypertensive rats.
    Pettersson A; Ricksten SE; Hedner J; Hedner T
    Acta Physiol Scand; 1988 Oct; 134(2):247-51. PubMed ID: 2976237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.